We are live on ! Find out more
FLNA

Filana Therapeutics

171 hedge funds and large institutions have $503M invested in Filana Therapeutics in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 57 increasing their positions, 52 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 52

1.6% less ownership

Funds ownership: 30.42%28.82% (-1.6%)

5% less funds holding

Funds holding: 180171 (-9)

15% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 40

17% less call options, than puts

Call options by funds: $199M | Put options by funds: $240M

34% less capital invested

Capital invested by funds: $757M → $503M (-$254M)

Holders
171
Holders Change
-9
Holders Change %
-5%
% of All Funds
2.63%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
34
Increased
57
Reduced
52
Closed
40
Calls
$199M
Puts
$240M
Net Calls
-$40.7M
Net Calls Change
-$6.79M
Name Holding Trade Value Shares
Change
Change in
Stake
EVM
151
Eaton Vance Management
Massachusetts
$3K
HPC
152
HM Payson & Co
Maine
$3K
VRM
153
Vectors Research Management
New York
$3K
MAM
154
McCarthy Asset Management
California
$3K +$420 +8 +13%
EFS
155
Econ Financial Services
Pennsylvania
$3K +$3.83K +73 New
BWM
156
BerganKDV Wealth Management
Minnesota
$2K
IFAM
157
Institutional & Family Asset Management
Colorado
$2K +$2.62K +50 New
PA
158
Parallel Advisors
California
$1K -$420 -8 -40%
SWM
159
Spire Wealth Management
Virginia
$1K
BFC
160
Bedel Financial Consulting
Indiana
$1K +$1.47K +28 New
OIA
161
Optimum Investment Advisors
Illinois
$1K +$1.57K +30 New
TIM
162
Tevis Investment Management
Texas
$1K +$1.57K +30 New
Manulife (Manufacturers Life Insurance)
163
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$846 -$18.5K -352 -2%
FHC
164
First Heartland Consultants
Missouri
$241 +$21K +400 +8%
Voloridge Investment Management
165
Voloridge Investment Management
Florida
-$13.8M -222,272 Closed
Millennium Management
166
Millennium Management
New York
-$7.25M -116,851 Closed
RPAM
167
Rhenman & Partners Asset Management
Sweden
-$5.28M -85,000 Closed
KPWS
168
Kestra Private Wealth Services
Texas
-$4.35M -70,000 Closed
D.E. Shaw & Co
169
D.E. Shaw & Co
New York
-$2.58M -49,269 Closed
Squarepoint
170
Squarepoint
New York
-$2.26M -36,405 Closed
BA
171
Bellwether Advisors
Nebraska
-$1.72M -27,769 Closed
State of New Jersey Common Pension Fund D
172
State of New Jersey Common Pension Fund D
New Jersey
-$1.61M -26,008 Closed
ECM
173
ExodusPoint Capital Management
New York
-$1.46M -23,487 Closed
Citadel Advisors
174
Citadel Advisors
Florida
-$1.12M -21,356 Closed
HT
175
HAP Trading
New York
-$726K -13,848 Closed

FLNA Hedge Fund Activity: Q4 2021 in Review

171 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q4 2021, worth a combined $503M — down 34% from $757M a quarter earlier.

Sellers outnumbered buyers: 40 funds closed out of FLNA and 34 opened new positions — a net loss of 6 holders — while 52 trimmed existing stakes and 57 added.

The largest buyer was Think Investments, opening a new position worth an estimated $10.6M. The largest seller was Group One Trading, cutting an estimated $16.8M.

  • 171 institutional investors held Filana Therapeutics (FLNA) as of Q4 2021, down from 180 in Q3 2021.
  • Funds reported $503M of Filana Therapeutics stock for Q4 2021, down 34% quarter-over-quarter.
  • 34 funds opened new Filana Therapeutics positions in Q4 2021 and 40 closed out, a net change of -6 holders.
  • The largest Filana Therapeutics buyer in Q4 2021 was Think Investments, an estimated $10.6M added.
  • The largest Filana Therapeutics seller in Q4 2021 was Group One Trading, an estimated $16.8M sold.

Based on aggregated 13F filings for Q4 2021.